In the new article “Effect of a Mobile-Health Intervention (A-CHESS) on Hepatitis C Testing Uptake Among People with Opioid Use Disorder: A Randomized Controlled Trial” in the journal JMIR mHealth and uHealth, the Health Information Technology Studies (HITS) group conducted an RCT to test the effectiveness of a mobile health intervention to increase hepatitis C virus awareness among people dealing with opioid use disorder.
The growing epidemic of opioid use disorder (OUD) and associated injection drug use has resulted in a surge of new hepatitis C virus (HCV) infections. Approximately half of the people with HCV infection are unaware of their HCV status. Improving HCV awareness and increasing screening among people with OUD are critical. Addiction-Comprehensive Health Enhancement Support System (A-CHESS) is an evidence-based, smartphone-delivered relapse prevention system that has been implemented among people with OUD who are receiving medications for addiction treatment (MAT) to improve long-term recovery.
Full citation: “Effect of a Mobile-Health Intervention (A-CHESS) on Hepatitis C Testing Uptake Among People with Opioid Use Disorder: A Randomized Controlled Trial,” Karli R. Hochstatter, David H. Gustafson Sr., Gina Landucci, Klaren Pe-Romashko, Olivia Cody, Adam Maus, Dhavan V. Shah and Ryan P. Westergaard, JMIR mHealth and uHealth, 9 (2): e23080. DOI: 10.2196/23080
Access the article: https://pubmed.ncbi.nlm.nih.gov/33616545/